Professional Documents
Culture Documents
Of Molecular Diseases
Diseases of the Blood
Anaemias
Anaemias
Haemoglobinopathies … Hb (protein)
∴ Genetic diseases
Genetic disorders
• autosomal dominant
• autosomal recessive
haemoglobinopathies (i.e. heterozygous or
homozygous)
• x-linked dominant
• x-linked recessive
Genes of Globin Chains
A. Point mutations .
B. Deletion mutations .
Mutations ( effect )
1. Transcriptional mutants.
2. RNA processing mutants.
3. RNA translation mutants.
4. Post-translational instability mutants.
Point mutations :
:Silent mutations.1
In third base of codon no change
.e.g. UCC UCA both give serine
: Mutations in promoter .2
Lead to inefficient transcription into mRNA
e.g.β .- thal
Cap site mutations : e.g. .3β- thal
:Read- through mutations .4
Change in termination codon longer Protein
e.g.α.- thal
:Missense mutations .5
.One amino acid change e.g. HbS
.Intron or exon e.g. B-thal
Mutations in splicing signals in forming mRNA .6
consensus mutation ) : defect in mRNA )
synthesis e.g.β. - thal
Mutations in polyadenylation of mRNA .7
precursor e.g.β .- thal
Mutation in initiation codon .8
:Non sense mutations .9
Formation of termination codon truncated
protein
e.g.β.- thal
:Frameshift mutations .10
Insertion or deletion of a single nucleotide
. within codon region
Reading frame is altered and subsequent
. codons are read
e.g.β- thal
Hb Wayne
.Table 1
β-Thalassaemia
80 – 90 million are carriers of β-thalassaemia gene (5%).
~170 different point mutations or small insertion/deletion
mutations, and ~17 gene deletions (25 bp – 67 kb) in
β-globin was discovered. Result in gene of :
β°- no β-globin, β+- severe deficiency, β++- mild .
Phenotypes are :
β-thalassaemia major,
β-thalassaemia intermedia,
β-thalassaemia minor,
Depending on the combination of β°- , β+- , β++-
Which comes from a low level or total absence of β-
globin chain.
• Mutations :-
2. Mutations in promoter:
Affect transcription (inefficient transcription
or mRNA synthesis) resulting in low level
of mRNA (20% normal),
i.e. β+- thal.
Table 2
Figure 4
Table 3 •
Cap site mutations. .2β+ .- thal
Table 2
Figure 4
Table 3 •
.3
a) Mutations at the splice junctions of introns,
where other donor cryptic sites lead to
untranslatable mRNA.β° . - thal
Table 2
Figure 4
Table 4
Figure 5
b) Changes in consensus sequence on either of
conserved dinucleotides of splice site lead to
normal and cryptic sites.β+.- thal
mutation could affect 3' acceptor site of intron 2
in which cryptic site lead to mRNA with a part
of 3' intron 2, but cryptic 3' site could spliced
. out with normal 5' acceptor
β+ .- thal
Figure 5
Table 2
Figure 4
c) Mutations within intron creating new 3'
acceptor splice site
Mutations within exon creating new 5, donor
splice site lead to new splice sites competing
. with normal site
β+ - thal.,β++ .- thal
Table 5
Mutations in polyadenylation of mRNA .4
. precursor
β++ .- thal
Table 2
Figure 4
Table 6
Mutations in initiation codon. .5
β°-thal
Table 6
Nonsense mutations giving rise to translation .6
termination codon ( leading to premature
termination of peptide synthesis ).β° . - thal
e. g. codon 17, AAG (lys) becomes UAG
.(a stop codon)
Table 2
Figure 4
Table 6
Frameshift mutations .7